FDA-Inspected Site

Omrix Biopharmaceuticals Ltd.

2 FDA inspections are on record for Omrix Biopharmaceuticals Ltd. in Nes-Ziona, Israel.

483· Form 483 issued

Nes-Ziona, Israel · Last updated July 11, 2026

Overview

  • 2 FDA inspections are on record.
  • 2 inspections produced a Form 483.
  • The most recent recorded inspection date is 2020-03-05.

At a glance

Inspections

2

Form 483s

2

EIRs

0

Last outcome

Form 483

Inspection history

FDA inspections on record, most recent first.

InspectionCategoryOutcomeForm 483
25 Feb 2020 – 5 Mar 2020Biologics483View 483 →
19 May 2011Not recorded483On file

Observations on record

Form 483 observations cited at this site, most recent first.

5 Mar 2020
21 CFR 211.160(a)

Following/documenting laboratory controls

Cited by Mihaly S Ligmond, Chava Kimchi Sarfaty, Steven E Bowen

5 Mar 2020
21 CFR 211.160(b)

Scientifically sound laboratory controls

Cited by Mihaly S Ligmond, Chava Kimchi Sarfaty, Steven E Bowen

5 Mar 2020
21 CFR 211.188(b)(8)

Labeling control records including specimens or copies

Cited by Mihaly S Ligmond, Chava Kimchi Sarfaty, Steven E Bowen

5 Mar 2020
21 CFR 211.194(a)(4)

Complete Test Data

Cited by Mihaly S Ligmond, Chava Kimchi Sarfaty, Steven E Bowen

Investigators

FDA investigators tied to this site in the record.

Chava Kimchi Sarfaty1 insp.

Recurring citations

CFR citation patterns observed across this site's inspections.

CitationWhat it coversCited
21 CFR 211.160(a)Cited across public-safe Form 483 observations1x
21 CFR 211.160(b)Cited across public-safe Form 483 observations1x
21 CFR 211.188(b)(8)Cited across public-safe Form 483 observations1x
21 CFR 211.194(a)(4)Cited across public-safe Form 483 observations1x

Full site report

Get the verbatim findings behind Omrix Biopharmaceuticals Ltd.'s 2 Form 483s

Source PDFs and recurring CFR citations, so your team knows what this site gets cited for.

  • The site's full inspection history, with every Form 483 and its outcome
  • Warning letters and recalls tied to the company behind it
  • Whether recurring CFR citations get closed out or repeat